Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
Adriano Lazzarin(Vita-Salute San Raffaele University), Miklos Salgo(La Roche College), Bonaventura Clotet(Universitat de Vic - Universitat Central de Catalunya), Jacques Reynes(Centre Hospitalier Universitaire de Montpellier), Cynthia Wat(Roche (United Kingdom)), John Delehanty(Tris Pharma (United States)), Claude Drobnes(Tris Pharma (United States)), Mark Nelson(University of Tasmania), Jean-François Delfraissy(Agence Nationale de Recherches sur le Sida et les Hépatites Virales), Keikawus Arastéh(Auguste-Viktoria-Klinik), Ralph DeMasi(Janssen (Belgium)), Les Huson(Hammersmith Hospital), David A. Cooper(UNSW Sydney), Joep M. A. Lange(University of Amsterdam), Hans-Jürgen Stellbrink(Universität Hamburg), Christine Katlama(Université Paris Cité)
Cited by 653
Related Papers
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
|Hepatology|2006|4.8k
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
|New England Journal of Medicine|1994|3.7k
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
|New England Journal of Medicine|2015|1.6k